A5040048191- Hepatocellular Carcinoma Treatment and Prognosis
- Liver Disease Diagnosis and Treatment
- Microbial Inactivation Methods
- Venous Thromboembolism Diagnosis and Management
- Renal and Vascular Pathologies
- Pulsed Power Technology Applications
- MRI in cancer diagnosis
- Liver Disease and Transplantation
- Gastroesophageal reflux and treatments
- Gastrointestinal disorders and treatments
- Renal Transplantation Outcomes and Treatments
- Pleural and Pulmonary Diseases
- Cancer Mechanisms and Therapy
- Advanced MRI Techniques and Applications
- Gastrointestinal Bleeding Diagnosis and Treatment
- Cancer, Stress, Anesthesia, and Immune Response
- Lung Cancer Diagnosis and Treatment
- Vascular Anomalies and Treatments
- Lung Cancer Research Studies
- Aortic aneurysm repair treatments
- Cardiac Valve Diseases and Treatments
- Aerosol Filtration and Electrostatic Precipitation
- Central Venous Catheters and Hemodialysis
- Organ Donation and Transplantation
- Cholangiocarcinoma and Gallbladder Cancer Studies
UCLA Medical Center
2021-2025
Ronald Reagan UCLA Medical Center
2021-2024
University of California, Los Angeles
2018-2024
Society of Interventional Radiology
2022
Columbia University Irving Medical Center
2015-2016
NewYork–Presbyterian Hospital
2015
Columbia University
2015
Background & Aims: CARTO and PARTO are well-accepted treatment for gastric variceal (GV) bleeding. However, long-term (>2 years) clinical outcomes have yet to be studied. In this study, we investigated outcomes, including overall survival (OS) in 10 years Methods: We performed a multi-national, multi-center, retrospective study of CARTO/PARTO GV treatments between 05/2012 07/2024. The primary were OS prognostic factors CARTO/PARTO. secondary clinical/technical success, complications,...
To assess the technical feasibility and safety of image-guided percutaneous biphasic monopolar pulsed electric field (PEF) ablation primary metastatic tumors.
To evaluate the efficacy of combination therapy using transarterial chemoembolization with microwave ablation (MWA) vs. MWA monotherapy for hepatocellular carcinomas (HCCs) >3 cm in size.This two-arm retrospective observational study included patients HCCs who underwent either (29 patients) or (35 between 2014 and 2020. The treatment outcomes related to primary efficacy, local tumor progression (LTP), control rate, overall survival were compared each cohort.The technical success 96.56%...
Nonalcoholic fatty liver disease (NAFLD) has reached pandemic proportions. Early detection can identify at-risk patients who be linked to hepatology care. The vibration-controlled transient elastography (VCTE) controlled attenuation parameter (CAP) is biopsy validated diagnose hepatic steatosis (HS). We aimed develop a novel clinical predictive algorithm for HS using the CAP score at Veterans' Affairs hospital. identified 403 in Greater Los Angeles VA Healthcare System with valid VCTEs...
Abstract Purpose Percutaneous ultrasound-guided renal biopsy is essential for diagnosing medical disorders in transplant kidneys. A variety of techniques have been advocated. The purpose this study to evaluate the safety and efficacy two different coaxial devices. Methods This single-center dual-arm, observation cohort included 1831 consecutive kidney biopsies performed over a 68-month period. Two were used, distinguished by whether 17 gauge (G) needle was advanced into cortex (intracapsular...
Combination transarterial embolization and ablation is an increasingly common strategy for treating solitary, non-resectable hepatocellular carcinomas (HCCs) greater than 3 cm in size. However, manufacturer guidelines do not provide information as to the size of zone after embolization. This can put patient at risk inadvertent thermal damage nearby anatomy such liver capsule, biliary ducts, diaphragm, body wall. Thus, while combination therapy associated with improved clinical outcomes, it...
Seven patients underwent microwave ablation of hepatic tumors; during ablation, a nerve plexus block was used for pain control. The mean visual analog scale (VAS) score (scale, 0-10) 0.3 ± 0.5 (SD) at baseline and 2.5 1.4, 2.6 2.3 0.9 1, 5, 10 minutes ablation. Two reported VAS 4 or greater which improved in both to 3 after one rescue sedation dose. remaining required no additional sedation. No major complication occurred. patient conversion general anesthesia.
Background: The purpose of this study was to evaluate and compare the clinical effectiveness costs using Caterpillar Arterial Embolization Device (Caterpillar) fibered coils in arterial embolization cases. Methods: In multicenter retrospective study, demographic, laboratory, procedural data were collected on a total 48 patients between February 2020 September 2020. Data 16 placements matched with 32 controls who underwent coil same vessel similar size. Clinical outcomes including type size...
Background: The purpose of this study is to describe a single institution’s experience using Oncozene (OZ) microspheres for transarterial chemoembolization (OZ-TACE) hepatocellular carcinoma (HCC), and compare tolerability, safety, short-term radiographic tumor response, progression-free survival (PFS), overall (OS) these procedures TACE (LC-TACE) performed with LC beads (LC). Methods: A retrospective, matched cohort patients undergoing DEB-TACE (drug-eluting bead chemoembolization) OZ or...